Lixisenatide is a peptide GLP-1 agonist, working in the same pathway as exenatide and liraglutide. It is being investigated for its ability to regulate cellular metabolism, reduce inflammation, and possibly slow the progression of neurodegenerative diseases.
Discover our Products
Science-based and high-quality devices
